Depression may make learning to avoid unpleasant events harder
The more depressive symptoms a person has, the more they struggle with learning to actively avoid unpleasant events.
2025-09-01
(Press-News.org) Depression alters how people pursue rewards, but, conversely, whether depressive symptoms influence how people learn to avoid nonrewarding, unpleasant events is less clear. Ryan Tomm and colleagues, from the University of British Colombia, addressed this question in their eNeuro paper to shed more light on the relationship between depression and learning. This work brought together researchers from preclinical, cognitive, and clinical backgrounds, building stronger connections across fields to better understand the mechanisms of depression.
The researchers developed a behavioral task for study volunteers based off rodent research that involves participants listening to sounds while looking at a screen with visual cues signaling sounds to come. Participants learned to avoid unpleasant sounds either by actively responding or withholding responses to cues. From a sample of 465 participants with a wide range of depressive symptoms from low to severe, the researchers found that people with more severe symptoms struggled to learn to actively avoid aversive sounds compared to those with less severe symptoms. However, once they did learn the task, their ability to actively avoid unpleasant sounds matched those with less symptoms. Thus, according to the authors, depressive symptoms may interfere specifically with learning to actively avoid unpleasant events, rather than with avoidance more broadly.
“What we still don’t know,” says Tomm, “is how depressive symptoms affect avoidance when people continue to learn after being proficient at an avoidance task, or in more complex situations where the best way to avoid something is unclear. As we actively explore these questions, we hope our work will provide a deeper understanding of how depression shapes avoidance behavior across different contexts.”
###
Please contact media@sfn.org for the full-text PDF.
About eNeuro
eNeuro is an online, open-access journal published by the Society for Neuroscience. Established in 2014, eNeuro publishes a wide variety of content, including research articles, short reports, reviews, commentaries and opinions.
About The Society for Neuroscience
The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 35,000 members in more than 95 countries.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-09-01
The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can disrupt normal brain development and function. Current treatments focus mainly on removing the tumor cells, but recent studies have shown that non-cancerous cells, such as nerve cells, also play a role in brain tumor formation and growth, suggesting novel approaches to treating these cancers.
Scientists have long known that a nerve cell signaling chemical called glutamate can increase growth of cancers throughout the body, but despite ...
2025-09-01
Common shrews are one of only a handful of mammals known to flexibly shrink and regrow their brains. This rare seasonal cycle, known as Dehnel’s phenomenon, has puzzled scientists for decades. How can a brain lose volume and regrow months later without sustaining permanent damage?
A study using non-invasive MRI has scanned the brains of shrews undergoing shrinkage, identifying a key molecule involved in the phenomenon: water.
“Our shrews lost nine percent of their brains during shrinkage, but the cells did not die,” says first author Dr. Cecilia Baldoni, a postdoctoral researcher from the Max Planck Institute of Animal Behavior ...
2025-09-01
UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a robotic arm or a computer cursor.
Published in Nature Machine Intelligence, the study shows that the interface demonstrates a new level of performance in noninvasive brain-computer interface, or BCI, systems. This could lead to a range of technologies to help people with limited physical capabilities, such as those with paralysis or neurological conditions, handle and move objects more easily and precisely.
The team developed custom algorithms to decode electroencephalography, or EEG — ...
2025-09-01
Black adults first hospitalized for heart failure in the U.S. at age 60.1, vs. 73.6 for white adults
Hispanic patients first hospitalized at 65.4; Asian American patients at 70.6
CHICAGO --- Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, reports a Northwestern Medicine study that analyzed data from more than 42,000 patients across hundreds of hospitals nationwide.
The study also found that Hispanic patients were hospitalized about eight years earlier than white patients, and Asian patients about three years earlier.
On average, white patients were first hospitalized ...
2025-09-01
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area. The finding, published in the journal Biological Research, raises concerns about the environmental circulation of microorganisms with high levels of resistance to critical clinically used antibiotics and reinforces the need for surveillance within the framework of "One Health."
The research, which was part of Franco Ilabaca's Master's thesis in Microbiology, was led by Dr. ...
2025-09-01
Conference: “Late Breaking Science” presentation at the European Society of Cardiology - AI driven cardiovascular biomarkers and clinical decisions
Title: Graph Neural Network Automation of Anticoagulation Decision-Making
Date: Embargo lifts Monday, September 1, 4:00 pm EDT
Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them with anticoagulants (blood thinner medications) to prevent stroke, which is currently the standard treatment course in this patient population. This model presents a completely ...
2025-09-01
About The Study: In this secondary analysis of the AZALEA-TIMI 71 randomized clinical trial, abelacimab consistently reduced the risk of bleeding relative to rivaroxaban irrespective of kidney function. These findings suggest that abelacimab may offer a particularly favorable safety profile among those with chronic kidney disease; however, larger studies are necessary to characterize the efficacy of abelacimab for stroke prevention in atrial fibrillation.
Corresponding Author: To contact the corresponding author, Siddharth M. Patel, MD, MPH, email spatel@bwh.harvard.edu.
To access the embargoed study: Visit our For ...
2025-09-01
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it. A new study from Radboud university medical center shows that AI can reliably take over this analysis and rapidly assess arteries for weak spots.
A heart attack occurs when a coronary artery, which supplies the heart with blood, is blocked by a blood clot. This can occur when atherosclerosis causes artery narrowing, resulting in the heart receiving too little oxygen. Treatment typically ...
2025-09-01
Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection, they can cause damage when unchecked. Led by researchers at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health with a multicenter team of leading ME/CFS researchers, the new study reveals molecular-level details into the syndrome’s lasting effects on inflammation and immune response that could inform the development of targeted therapeutic interventions to ...
2025-09-01
SAN ANTONIO, Sept. 1, 2025 – UTSA and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today merged to form The University of Texas at San Antonio (UT San Antonio), a premier global university that is deeply committed to making lives better for the communities it serves. As a merged institution, UT San Antonio now ranks as the third-largest public research university in Texas according to annual research expenditures, behind only Texas A&M University and the University of Texas at Austin.
UT San Antonio’s comprehensive enterprise now includes approximately 40,000 students, 17,000 employees and more than $486 million in annual ...
LAST 30 PRESS RELEASES:
[Press-News.org] Depression may make learning to avoid unpleasant events harder
The more depressive symptoms a person has, the more they struggle with learning to actively avoid unpleasant events.
